Cardiac And Inflammatory Biomarkers And New Or Worsening Heart Failure In High-risk Patients With COVID-19
Conference abstract
[키워드] adverse outcome
age
association
average
baseline
biochemical marker
BNP
C-reactive protein
cardiac
Cardiomyopathy
cell activation
clinical
collected
condition
consequence
coronary syndrome
COVID-19
Cytokines
decrease
defined
develop
Diagnosis
discharge
dysfunction
Ejection fraction
elevated
enrolled
failure
Follow-up
greater
groups
heart
Hospital admission
Hospitalized
hsCRP
identify
IL-6
Immune cell
Inflammation
Inflammatory biomarker
inflammatory biomarkers
Inflammatory marker
interleukin-6
interquartile range
IQR
Ischemia
male
management
measure
mechanism
median
multifactorial
myocardial injury
myocarditis
New
no significant difference
Patient
peptide
performed
plasma
pro-inflammatory cytokine storm
profile
prospective cohort study
quantification
reported
Result
risk factor
sensitivity
serum
specimen
Subtypes
syndrome
Trigger
troponin levels
ventricular
with COVID-19
worsening
[DOI] 10.1016/j.cardfail.2022.03.243 [Article Type] Conference abstract
[DOI] 10.1016/j.cardfail.2022.03.243 [Article Type] Conference abstract